Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Owing to its unique structure and mode of action, SS-31 demonstrates potential therapeutic value across cardiovascular diseases, neurodegenerative disorders, kidney injury, and myopathies associated with mitochondrial dysfunction 1-6
Severe caloric restriction accelerates muscle loss and may impair hormonal function
By following the guidelines outlined in this article, researchers can ensure that their peptides remain stable and effective for their intended use
Be the first to read: Authors: Giuseppe Consorti, Enrico Betti, Mariagrazia Paglianiti, Lisa Catarzi, Gabriele Monarchi, Massimiliano Gilli, Stefania Troise, Carlos Miguel Chiesa-Estomba, Luigi Angelo Vaira and Giulio Cirignaco
Orphan drug status typically includes benefits such as extended market exclusivity, tax credits for clinical research, and reduced regulatory fees
Patients with personal or family history of medullary thyroid carcinoma or MEN2 must not use these medications
